Evidence map›Paper›PMID 24259189›Full record

Trial reportSexually transmitted infections2014

Male circumcision and Mycoplasma genitalium infection in female partners: a randomised trial in Rakai, Uganda.

Aaron A R Tobian, Charlotte Gaydos, Ronald H Gray, Godfrey Kigozi, David Serwadda, Nicole Quinn, Mary K Grabowski, Richard Musoke, Anthony Ndyanabo, Fred Nalugoda and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Sexually transmitted infections, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Prevalence ofSexually transmitted infections · 2018
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Aaron A R TobianDepartment of Pathology, School of Medicine, Johns Hopkins University, , Baltimore, Maryland, USA.
Charlotte Gaydos
Ronald H Gray
Godfrey Kigozi
David Serwadda
Nicole Quinn
Mary K Grabowski
Richard Musoke
Anthony Ndyanabo
Fred Nalugoda
Maria J Wawer
Thomas C Quinn
Rakai Health Sciences Program · UGJohns Hopkins University · USJohns Hopkins Medicine · US

Funding

LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
TrainingU54EB007958 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI Yukari C Manabe · 2007 to 2026
$34.6M
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Male Circumcision Trial for HIV Prevention, Rakai-UgandaU01AI051171 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2002 to 2006
$8.9M
International Training/Research in Population and Health, UgandaD43TW001508 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2000 to 2010
$2.1M
Oncogenic HPV, Mucosal Immune Response and Risk of HIV AcquisitionK23AI093152 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2011 to 2015
$684k
SPECIAL POSTDOCTORAL RESEARCH PROGRAM IN AIDST22TW000015 · FIC · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCOTT, GWENDOLYN B. · 1988 to 1999
–
FIC NIH HHS 5D43TW001508FIC NIH HHS D43TW00015FIC NIH HHS D43 TW001508FIC NIH HHS T22 TW000015NIAID NIH HHS K23 AI093152NIAID NIH HHS NIH 1K23AI093152-01A1NIAID NIH HHS U01 AI051171NIAID NIH HHS U01 AI068613NIAID NIH HHS U1AI51171NIAID NIH HHS UM1 AI068613NIBIB NIH HHS U54 EB007958NIBIB NIH HHS U54EB007958PHS HHS A1U0168613
6 · The paper itself

Abstract

objectivePrevious randomised trial data have demonstrated that male circumcision reduces Mycoplasma genitalium prevalence in men. We assessed whether male circumcision also reduces M genitalium infection in female partners of circumcised men.

methodsHIV-negative men were enrolled and randomised to either male circumcision or control. Female partners of male trial participants from the intervention (n=437) and control (n=394) arms provided interview information and self-collected vaginal swabs that were tested for M genitalium by APTIMA transcription-mediated amplification-based assay. Prevalence risk ratios (PRR) and 95% CI of M genitalium prevalence in intervention versus control group were estimated using Poisson regression. Analysis was by intention-to-treat. An as-treated analysis was conducted to account for study-group crossovers.

resultsMale and female partner enrolment sociodemographic characteristics, sexual behaviours, and symptoms of sexually transmitted infections were similar between study arms. Female M genitalium prevalence at year 2 was 3.2% (14/437) in the intervention arm and 3.6% (14/394) in the control arm (PRR=0.90, 95% CI 0.43 to 1.89, p=0.78). In an as-treated analysis, the prevalence of M genitalium was 3.4% in female partners of circumcised men and 3.3% in female partners of uncircumcised men (PRR=1.01, 95% CI 0.48 to 2.12, p=0.97).

conclusionsContrary to findings in men, male circumcision did not affect M genitalium infection in female partners.

Indexed as

Circumcision, MaleSexual PartnersAdolescentAdultFemaleHIV InfectionsHumansIncidenceMaleMiddle AgedMolecular Diagnostic TechniquesMycoplasma genitaliumMycoplasma InfectionsPoisson DistributionRisk FactorsSexual BehaviorCircumcisionEpidemiology (Clinical)Mycoplasma

Identifiers

PMID24259189
PMCPMC4018720
OpenAlexW2118685780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.